Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 497-503

  Mentz, Robert J ^a   Babyak, Michael A ^a   Bittner, Vera ^b   Fleg, Jerome L ^b   Keteyian, Steven J ^c   Swank, Ann M ^d   Pinã, Ileana L ^e   Kraus, William E ^a   Whellan, David J ^f   O'Connor, Christopher M ^a   Blumenthal, James A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

blacks; depression; heart failure; outcome assessment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BLACK PERSON; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; EVENT FREE SURVIVAL; FEMALE; FUNCTIONAL STATUS; GENERAL CONDITION DETERIORATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; AFRICAN AMERICAN; CAUCASIAN; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; ETHNOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; KINESIOTHERAPY; MIDDLE AGED; MORTALITY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AGED; DEPRESSION; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE THERAPY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84942870855     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001995     Document Type: Article

References (34)

1. Dries DL, Exner DV, Gersh BJ, Cooper HA, Carson PE, Domanski MJ. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med. 1999;340:609-616. doi: 10.1056/NEJM199902253400804.
2. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, Williams OD, Hulley SB. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360:1179-1190. doi: 10.1056/NEJMoa0807265.
3. Yancy CW. Heart failure in African Americans: a cardiovascular engima. J Card Fail. 2000;6:183-186.
4. Yancy CW, Strong M. The natural history, epidemiology, and prognosis of heart failure in African Americans. Congest Heart Fail. 2004;10:15-8; quiz 21.
5. Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA. 2011;305:675-681. doi: 10.1001/jama.2011.123.
6. Mentz RJ, Bittner V, Schulte PJ, Fleg JL, Pinã IL, Keteyian SJ, Moe G, Nigam A, Swank AM, Onwuanyi AE, Fitz-Gerald M, Kao A, Ellis SJ, Kraus WE, Whellan DJ, O'Connor CM. Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure: a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION). Am Heart J. 2013;166:488-495. doi: 10.1016/j.ahj.2013.06.002.
7. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38:199-205.
8. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail. 2003;9:163-169.
9. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF Jr, Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med. 2007;167:367-373. doi: 10.1001/archinte.167.4.367.
10. Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR, O'Connor CM. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J. 2007;154:102-108. doi: 10.1016/j.ahj.2007.03.043.
11. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O'Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849-1856.
12. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527-1537. doi: 10.1016/j.jacc.2006.06.055.
13. Sherwood A, Blumenthal JA, Hinderliter AL, Koch GG, Adams KF Jr, Dupree CS, Bensimhon DR, Johnson KS, Trivedi R, Bowers M, Christenson RH, O'Connor CM. Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol. 2011;57:418-423. doi: 10.1016/j.jacc.2010.09.031.
14. Whellan DJ, O'Connor CM, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Pinã IL; HF-ACTION Trial Investigators. Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J. 2007;153:201-211. doi: 10.1016/j.ahj.2006.11.007.
15. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pinã IL; HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-1450. doi: 10.1001/jama.2009.454.
16. Flynn KE, Pinã IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP; HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451-1459. doi: 10.1001/jama.2009.457.
17. Blumenthal JA, Babyak MA, O'Connor C, Keteyian S, Landzberg J, Howlett J, Kraus W, Gottlieb S, Blackburn G, Swank A, Whellan DJ. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308:465-474. doi: 10.1001/jama.2012.8720.
18. Felker GM, Whellan D, Kraus WE, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Pinã IL, O'Connor CM; HF-ACTION Investigators. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HFACTION) study. Am Heart J. 2009;158(4 Suppl):S37-S44. doi: 10.1016/j.ahj.2009.07.011.
19. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual. 2nd ed. San Antonio, TX: Psychological Corp; 1996.
20. American Psychiatric Association. Task Force on DSM-IV Diagnostic and Statistical Manual Of Mental Disorders (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
21. Whisman MA, Judd CM, Whiteford NT, Gelhorn HL. Measurement invariance of the Beck Depression Inventory-Second Edition (BDIII) across gender, race, and ethnicity in college students. Assessment. 2013;20:419-428. doi: 10.1177/1073191112460273.
22. Mentz RJ, Schulte PJ, Fleg JL, Fiuzat M, Kraus WE, Pinã IL, Keteyian SJ, Kitzman DW, Whellan DJ, Ellis SJ, O'Connor CM. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J. 2013;165:193-199. doi: 10.1016/j.ahj.2012.10.029.
23. Stone CJ, Koo CY. Additive Splines in Statistics. Proceedings of the Statistical Computing. Washington, DC: American Statistical Association; 1985.
24. Waldman SV, Blumenthal JA, Babyak MA, Sherwood A, Sketch M, Davidson J, Watkins LL. Ethnic differences in the treatment of depression in patients with ischemic heart disease. Am Heart J. 2009;157:77-83. doi: 10.1016/j.ahj.2008.08.013.
25. O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, Krishnan R; SADHART-CHF Investigators. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010;56:692-699. doi: 10.1016/j. jacc.2010.03.068.
26. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, Mclvor M; Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
27. Holzapfel N, Löwe B, Wild B, Schellberg D, Zugck C, Remppis A, Katus HA, Haass M, Rauch B, Jünger J, Herzog W, Müller-Tasch T. Self-care and depression in patients with chronic heart failure. Heart Lung. 2009;38:392-397. doi: 10.1016/j.hrtlng.2008.11.001.
28. Jiang W, Krishnan R, Kuchibhatla M, Cuffe MS, Martsberger C, Arias RM, O'Connor CM; SADHART-CHF Investigators. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol. 2011;107:545-551. doi: 10.1016/j.amjcard.2010.10.013.
29. Bekelman DB, Havranek EP, Becker DM, Kutner JS, Peterson PN, Wittstein IS, Gottlieb SH, Yamashita TE, Fairclough DL, Dy SM. Symptoms, depression, and quality of life in patients with heart failure. J Card Fail. 2007;13:643-648. doi: 10.1016/j.cardfail.2007.05.005.
30. Rimer J, Dwan K, Lawlor DA, Greig CA, McMurdo M, Morley W, Mead GE. Exercise for depression. Cochrane Database Syst Rev. 2012;7:CD004366. doi: 10.1002/14651858.CD004366.pub5.
31. Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, O'Hayer CV, Mabe S, Johnson J, Doraiswamy PM, Jiang W, Schocken DD, Hinderliter AL. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60:1053-1063. doi: 10.1016/j.jacc.2012.04.040.
32. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69:587-596. doi: 10.1097/PSY.0b013e318148c19a.
33. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88:337-341.
34. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64:2281-2293. doi: 10.1016/j.jacc.2014.08.036.